- EXCELLENT OPERATING PERFORMANCE ACHIEVED.
- MARKET LEADERSHIP FURTHER STRENGTHENED.
- FOCUS ON RENAL PHARMACEUTICALS CONTINUED.
Fresenius Group
Business Segments
Fresenius Medical Care We presented the first interim results of the demonstration project in the past year. Among other things, these revealed that approximately one-third of the average costs per patient of 80,900 US$ were caused by hospital stays. This indicates the cost-saving potential of in-hospital care. Overall, the demonstration project’s quality objectives were met and even exceeded in some cases. The number of hospitalizations dropped significantly: The average of 1.7 hospitalizations per patient achieved in the first year of the project corresponds to an improvement of 15% compared with other data available for the whole United States. Altogether, about 1,000 patients took part in this project by the end of 2007.
Despite the good interim results, the project’s final outcome remains open: CMS will be considering further action only at the end of the project’s four-year duration. We are convinced that with this comprehensive care program we can achieve even better treatment results for our patients and also reduce costs. As a vertically integrated provider of dialysis care and products we consider ourselves well positioned to profit from the trend towards Disease Management programs.
For further information, please see Fresenius Medical Care’s Annual Report 2007 or www.fmc-ag.com.





